☆ 4.5 Letter

A sporadic multiple GIST with unusual pathologic, molecular, and genetic features

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)

Journal

AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Volume 32, Issue 2, Pages 340-341

Publisher

LIPPINCOTT WILLIAMS & WILKINS

DOI: 10.1097/PAS.0b013e3180cac5f7

Keywords

-

Categories

Pathology Surgery

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Genetics & Heredity

Cross Analysis of Genomic-Pathologic Features on Multiple Primary Hepatocellular Carcinoma

Fei Ren, Depin Wang, Xueyuan Zhang, Na Zhao, Xiaowen Wang, Yu Zhang, Li Li

Summary: This study investigated the pathological and genomic mutation patterns of multifocal hepatocellular carcinoma. The intrahepatic metastasis pattern had a poorer survival outcome and was associated with certain gene mutations. Based on these findings, a model was proposed to differentiate the patterns of multifocal hepatocellular carcinoma using pathological and genomic information.

FRONTIERS IN GENETICS (2022)

Add to Collection

Article Multidisciplinary Sciences

Patient similarity network of newly diagnosed multiple myeloma identifies patient subgroups with distinct genetic features and clinical implications

Sherry Bhalla, David T. Melnekoff, Adolfo Aleman, Violetta Leshchenko, Paula Restrepo, Jonathan Keats, Kenan Onel, Jeffrey R. Sawyer, Deepu Madduri, Joshua Richter, Shambavi Richard, Ajai Chari, Hearn Jay Cho, Joel T. Dudley, Sundar Jagannath, Alessandro Lagana, Samir Parekh

Summary: MM-PSN is the first multiomics patient similarity network for multiple myeloma, accurately dissecting the genetic and molecular landscape of the disease and identifying 12 distinct patient subgroups. These subgroups provide important information for patient prognosis and clinical management.

SCIENCE ADVANCES (2021)

Add to Collection

Article Oncology

Case Report: Malignant Primary Sellar Paraganglioma With Unusual Genetic and Imaging Features

Stefan Stojanoski, Henning Buensow Boldt, Dusko Kozic, Attila Patocs, Marta Korbonits, Milica Medic-Stojanoska, Olivera Casar-Borota

Summary: A rare case of malignant paraganglioma originating from the sellar region was reported, with genetic abnormalities in ATRX and TP53 genes. The patient presented with atypical imaging features and responded to treatment with somatostatin LAR and PRRT targeting mutated ATRX gene. This case suggests ATRX gene mutation as a potential therapeutic marker in paraganglioma.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Pathology

Pediatric-Type Indolent B-Cell Lymphomas With Overlapping Clinical, Pathologic, and Genetic Features

Sojung Lim, Ka Young Lim, Jiwon Koh, Jeong Mo Bae, Hongseok Yun, Cheol Lee, Young A. Kim, Jin Ho Paik, Yoon Kyung Jeon

Summary: This study analyzed the clinicopathologic and genetic features of pediatric-type follicular lymphoma (PTFL) and pediatric nodal marginal zone lymphoma (PNMZL). The findings suggest that PTFL and PNMZL are similar diseases with overlapping features. Mixed type tumors and atypical adult cases were also observed. The disease spectrum of pediatric-type indolent B-cell lymphomas (PedIBCL) may be broader than previously believed.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2022)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Correlation of CT radiomic features for GISTs with pathological classification and molecular subtypes: preliminary and monocentric experience

Daniele Palatresi, Filippo Fedeli, Ginevra Danti, Elisa Pasqualini, Francesca Castiglione, Luca Messerini, Daniela Massi, Silvia Bettarini, Paolo Tortoli, Simone Busoni, Silvia Pradella, Vittorio Miele

Summary: The purpose of this study was to identify CT radiomic features that could correlate with the risk class and treatment response of gastrointestinal stromal tumors (GISTs). By analyzing CT images, the study found several statistically significant features that could be used to assess the risk class and prognosis of GISTs.

RADIOLOGIA MEDICA (2022)

Add to Collection

Article Medicine, General & Internal

Comparison of Clinical Outcomes, Pathologic Characteristics, and Immune-Related Features of Postradiation vs Sporadic Oral Cavity Squamous Cell Carcinoma

James C. H. Chow, Wah Cheuk, William C. S. Cho, Chi-Fai Wong, Dennis W. Y. Au, Anthony H. P. Tam, Rachel C. W. Wong, Jeffrey C. H. Chan, Simon C. C. Law, Roger K. C. Ngan, Kam-Hung Wong, Ka-Man Cheung

Summary: This retrospective matched cohort study found distinctive pathologic characteristics and relapse patterns of postradiation OCSCC compared with sporadic OCSCC, which may be attributable to the lack of adjuvant radiotherapy, aggressive biologic phenotype, and different host immune response. Further exploration of the role of immune checkpoint therapy may be justified.

JAMA NETWORK OPEN (2023)

Add to Collection

Article Health Care Sciences & Services

Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma

Martina Ruscelli, Thais Maloberti, Angelo Gianluca Corradini, Francesca Rosini, Giulia Querzoli, Marco Grillini, Annalisa Altimari, Elisa Gruppioni, Viviana Sanza, Alessia Costantino, Riccardo Ciudino, Matteo Errani, Alessia Papapietro, Sara Coluccelli, Daniela Turchetti, Martina Ferioli, Susanna Giunchi, Giulia Dondi, Marco Tesei, Gloria Ravegnini, Francesca Abbati, Daniela Rubino, Claudio Zamagni, Emanuela D'Angelo, Pierandrea De Iaco, Donatella Santini, Claudio Ceccarelli, Anna Myriam Perrone, Giovanni Tallini, Dario de Biase, Antonio De Leo

Summary: This study aims to evaluate the impact of integrated molecular and pathologic risk stratification in the clinical practice of endometrial carcinoma (EC). It found that molecular classes and risk groups were correlated with disease-free survival. The study supports the prognostic importance of EC molecular classification and the essential role of histopathologic assessment in patients' management.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Add to Collection

Article Endocrinology & Metabolism

Pathologic Features Associated With Molecular Subtypes of Well-Differentiated Thyroid Cancer

Alice L. Tang, Richard T. Kloos, Benjamin Aunins, Tammy M. Holm, Mara Y. Roth, Michael W. Yeh, Gregory W. Randolph, Meredith E. Tabangin, Mekibib Altaye, David L. Steward

Summary: The study found that pathological features such as metastasis, gross extra-thyroidal extension, and multifocality were more prevalent in BRAF-like tumors compared to RAS-like and NBNR. A trend towards increased frequency of angioinvasion was observed in RAS-like and NBNR cancers. Further research is needed to evaluate the impact of preoperative knowledge of molecular mutations on decision-making regarding the extent of surgery.

ENDOCRINE PRACTICE (2021)

Add to Collection

Article Behavioral Sciences

Genetic and clinical features of Chinese sporadic amyotrophic lateral sclerosis patients with TARDBP mutations

Feng Feng, Hongfen Wang, Jiajin Liu, Zhanjun Wang, Baixuan Xu, Kun Zhao, Xiaoyong Tao, Zhengqing He, Fei Yang, Xusheng Huang

Summary: Our study investigated the genetic and clinical features of Chinese sporadic ALS patients with TARDBP mutations. We found a low frequency of TARDBP missense mutations in Chinese SALS patients (0.77%). The results demonstrate that TARDBP mutation is a rare cause of Chinese SALS patients and expand the spectrum of phenotype.

BRAIN AND BEHAVIOR (2021)

Add to Collection

Article Pathology

Renal oncocytoma with adverse pathologic features: a clinical and pathologic study of 50 cases

Khaleel Al-Obaidy, Liang Cheng

Summary: Renal oncocytoma is the most common benign epithelial renal neoplasm, and even with adverse features that are often seen in renal cell carcinomas, they do not change its benign course. A large institutional series of renal oncocytoma with adverse pathologic features was reported, showing no tumor recurrence or metastasis in patients during follow-up.

MODERN PATHOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Patient demographics, clinicopathologic features, and outcomes in wild-type gastrointestinal stromal tumor: a national cohort analysis

Tahsin M. Khan, Emily A. Verbus, Alexander J. Rossi, Jonathan M. Hernandez, Jeremy L. Davis, Brian A. Coakley, Andrew M. Blakely

Summary: Wild-type KIT and PDGFRA gastrointestinal stromal tumors are rare and have limited treatment options. This study analyzed data from a large national database to identify factors influencing overall survival, finding that tumors in the small intestine and with high mitotic count were associated with decreased OS. Surgery remains the primary treatment modality for wild-type GIST.

SCIENTIFIC REPORTS (2022)

Add to Collection

Article Oncology

Chromosomal instability and a deregulated cell cycle are intrinsic features of high-risk gastrointestinal stromal tumours with a metastatic potential

Heidi Maria Namlos, Ksenia Khelik, Sigve Nakken, Daniel Vodak, Eivind Hovig, Ola Myklebost, Kjetil Boye, Leonardo A. Meza-Zepeda

Summary: Patients with localised, high-risk gastrointestinal stromal tumours (GIST) who receive adjuvant imatinib treatment may still relapse within 3 years. Current risk classification methods are not accurate in predicting poor outcomes after standard treatment. This study aimed to identify genomic and transcriptomic profiles associated with disease relapse and a more aggressive phenotype. The findings suggest that increased chromosomal instability is an intrinsic feature for metastasizing tumours and could serve as a novel prognostic biomarker for high-risk GIST.

MOLECULAR ONCOLOGY (2023)

Add to Collection

Article Obstetrics & Gynecology

NUT Carcinoma in the Pelvic Cavity With Unusual Pathologic Features

Minsun Jung, Se Ik Kim, Jae-Weon Kim, Yoon Kyung Jeon, Cheol Lee

Summary: This article describes an extraordinary case of NUT carcinoma in the pelvic cavity. Pathological examination revealed tumor cells with monotonous-round morphology and immunohistochemical analysis confirmed the expression of related markers. Genetic testing confirmed the NUTM1 translocation. NUT carcinoma should be considered in the differential diagnosis of poorly differentiated malignancies in the pelvic organs.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2022)

Add to Collection

Review Medicine, General & Internal

The Clinical and Neuropathological Features of Sporadic (Late-Onset) and Genetic Forms of Alzheimer's Disease

Tanzil Rujeedawa, Eva Carrillo Felez, Isabel C. H. Clare, Juan Fortea, Andre Strydom, Anne-Sophie Rebillat, Antonia Coppus, Johannes Levin, Shahid H. Zaman

Summary: Genetic and acquired Alzheimer's disease have different clinical and pathological characteristics, with Down syndrome-associated AD and Autosomal Dominant AD appearing in younger populations with a wider range of manifestations, while late-onset AD is mainly influenced by age-related comorbidities.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Clinical Neurology

Multiple genetic variants involved in both autoimmunity and autoinflammation detected in Chinese patients with sporadic Meniere's disease: a preliminary study

Jing Zou, Guoping Zhang, Hongbin Li, Zikai Zhao, Qing Zhang, Ilmari Pyykko, Antti Makitie

Summary: The purpose of this study was to identify genetic variants associated with immune regulation in Meniere's disease. Whole genome sequencing of 16 Chinese patients revealed multiple genetic variants involved in immune regulation, which may make patients susceptible to autoimmune and inflammatory reactions under internal stress.

FRONTIERS IN NEUROLOGY (2023)

Add to Collection

Article Oncology

Dose-Dense Temozolomide in Patients with MGMT-Silenced Chemorefractory Colorectal Cancer

Filippo Pietrantonio, Filippo de Braud, Massimo Milione, Claudia Maggi, Roberto Iacovelli, Katia Fiorella Dotti, Federica Perrone, Elena Tamborini, Marta Caporale, Rosa Berenato, Giorgia Leone, Alessio Pellegrinelli, Ilaria Bossi, Fabrizio Festinese, Stefano Federici, Maria Di Bartolomeo

TARGETED ONCOLOGY (2016)

Add to Collection

Article Oncology

Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b

Elisabetta Vergani, Lorenza Di Guardo, Matteo Dugo, Sara Rigoletto, Gabrina Tragni, Roberta Ruggeri, Federica Perrone, Elena Tamborini, Annunziata Gloghini, Flavio Arienti, Barbara Vergani, Paola Deho, Loris De Cecco, Viviana Vallacchi, Paola Frati, Eriomina Shahaj, Antonello Villa, Mario Santinami, Filippo De Braud, Licia Rivoltini, Monica Rodolfo

ONCOTARGET (2016)

Add to Collection

Article Oncology

Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 Syndrome

Daniela Gasparotto, Sabrina Rossi, Maurizio Polano, Elena Tamborini, Erica Lorenzetto, Marta Sbaraglia, Alessia Mondello, Marco Massani, Stefano Lamon, Raffaella Bracci, Alessandra Mandolesi, Elisabetta Frate, Franco Stanzial, Jerin Agaj, Guido Mazzoleni, Silvana Pilotti, Alessandro Gronchi, Angelo Paolo Dei Tos, Roberta Maestro

CLINICAL CANCER RESEARCH (2017)

Add to Collection

Article Oncology

Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer

Filippo Pietrantonio, Claudio Vernieri, Giulia Siravegna, Alessia Mennitto, Rosa Berenato, Federica Perrone, Annunziata Gloghini, Elena Tamborini, Sara Lonardi, Federica Morano, Benedetta Picciani, Adele Busico, Chiara Costanza Volpi, Antonia Martinetti, Francesca Battaglin, Ilaria Bossi, Alessio Pellegrinelli, Massimo Milione, Chiara Cremolini, Maria Di Bartolomeo, Alberto Bardelli, Filippo de Braud

CLINICAL CANCER RESEARCH (2017)

Add to Collection

Article Oncology

Immunohistochemical and molecular profile of salivary gland cancer in children

Laura D. Locati, Paola Collini, Martina Imbimbo, Marta Barisella, Adele Testi, Lisa F. Licitra, Thomas Loening, Katharina Tiemann, Pasquale Quattrone, Emanuela Bimbatti, Stefano Chiaravalli, Michela Casanova, Elena Tamborini, Roberto Carta, Patrizia Gasparini, Marco Guzzo, Maura Massimino, Andrea Ferrari

PEDIATRIC BLOOD & CANCER (2017)

Add to Collection

Meeting Abstract Oncology

Liquid biopsy to predict benefit from rechallenge with cetuximab (cet) plus irinotecan (iri) in RAS/BRAF wild-type metastatic colorectal cancer patients (pts) with acquired resistance to first-line cet plus iri: Final results and translational analyses of the CRICKET study by GONO.

Daniele Rossini, Chiara Cremolini, Elena Conca, Marzia Del Re, Adele Busico, Filippo Pietrantonio, Francesca Bergamo, Romano Danesi, Mariaelena Casagrande, Emiliano Tamburini, Emanuela Dell'Aquila, Antonia Strippoli, Gianluca Masi, Giuseppe Tonini, Francesca Negri, Domenico C. Corsi, Paola Ermacora, Rossana Intini, Alfredo Falcone, Daniele Santini

JOURNAL OF CLINICAL ONCOLOGY (2018)

Add to Collection

Article Oncology

Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan A Phase 2 Single-Arm Clinical Trial

Chiara Cremolini, Daniele Rossini, Emanuela Dell'Aquila, Sara Lonardi, Elena Conca, Marzia Del Re, Adele Busico, Filippo Pietrantonio, Romano Danesi, Giuseppe Aprile, Emiliano Tamburini, Carlo Barone, Gianluca Masi, Francesco Pantano, Francesca Pucci, Domenico C. Corsi, Nicoletta Pella, Francesca Bergamo, Eleonora Rofi, Cecilia Barbara, Alfredo Falcone, Daniele Santini

JAMA ONCOLOGY (2019)

Add to Collection

Article Dermatology

Identification of potentially druggable molecular alterations in skin adnexal malignancies

Stefano Cavalieri, Adele Busico, Iolanda Capone, Elena Conca, Elena Dallera, Pasquale Quattrone, Lisa Licitra, Giancarlo Pruneri, Paolo Bossi, Federica Perrone

JOURNAL OF DERMATOLOGY (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Molecular Signatures for Combined Targeted Treatments in Diffuse Malignant Peritoneal Mesothelioma

Antonino Belfiore, Adele Busico, Fabio Bozzi, Silvia Brich, Elena Dallera, Elena Conca, Iolanda Capone, Annunziata Gloghini, Chiara C. Volpi, Antonello D. Cabras, Silvana Pilotti, Dario Baratti, Marcello Guaglio, Marcello Deraco, Shigeki Kusamura, Federica Perrone

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Add to Collection

Article Oncology

SDHA Germline Variants in Adult Patients With SDHA-Mutant Gastrointestinal Stromal Tumor

Maria A. Pantaleo, Milena Urbini, Angela Schipani, Margherita Nannini, Valentina Indio, Antonio De Leo, Bruno Vincenzi, Antonella Brunello, Giovanni Grignani, Mariaelena Casagrande, Elena Fumagalli, Elena Conca, Maristella Saponara, Elisa Gruppioni, Annalisa Altimari, Dario De Biase, Giovanni Tallini, Gloria Ravegnini, Daniela Turchetti, Marco Seri, Andrea Ardizzoni, Paola Secchiero, Annalisa Astolfi

Summary: Germline SDHA variants are highly prevalent in SDHA-deficient GIST, and the disease may occur in older adults as well. Genetic testing and surveillance should be conducted for SDHA mutation carriers and their relatives.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Article Oncology

Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O6-Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer: The MAYA Trial

Federica Morano, Alessandra Raimondi, Filippo Pagani, Sara Lonardi, Lisa Salvatore, Chiara Cremolini, Sabina Murgioni, Giovanni Randon, Federica Palermo, Lorenzo Antonuzzo, Nicoletta Pella, Patrizia Racca, Michele Prisciandaro, Monica Niger, Francesca Corti, Francesca Bergamo, Alberto Zaniboni, Margherita Ratti, Michele Palazzo, Celeste Cagnazzo, Maria Alessandra Calegari, Federica Marmorino, Iolanda Capone, Elena Conca, Adele Busico, Silvia Brich, Elena Tamborini, Federica Perrone, Massimo Di Maio, Massimo Milione, Maria Di Bartolomeo, Filippo de Braud, Filippo Pietrantonio

Summary: This trial evaluated the efficacy and safety of an immune-sensitizing strategy in patients with MSS and MGMT-silenced mCRC. The results showed that a combination of temozolomide priming followed by low-dose ipilimumab and nivolumab may induce durable clinical benefit in these patients.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection

Article Oncology

BYL719 (alpelisib) for the treatment of PIK3CA-mutated, recurrent/advanced cervical cancer

Giorgio Bogani, Valentina Chiappa, Marta Bini, Dominique Ronzulli, Alice Indini, Elena Conca, Francesco Raspagliesi

Summary: The study reports the preliminary experience of using BYL719 (alpelisib) in patients with advanced/recurrent cervical cancer who have failed at least two lines of treatment. The results show a high level of efficacy and tolerability of alpelisib in this patient population. Further trials are needed to assess the safety and effectiveness of alpelisib in PIK3CA-mutated recurrent/advanced cervical cancer.

TUMORI JOURNAL (2023)

Add to Collection

Article Oncology

Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model

Jacopo Azzollini, Andrea Vingiani, Luca Agnelli, Elena Tamborini, Federica Perrone, Elena Conca, Iolanda Capone, Adele Busico, Bernard Peissel, Erica Rosina, Monika Ducceschi, Mara Mantiero, Salvatore Lopez, Francesco Raspagliesi, Monica Niger, Matteo Duca, Silvia Damian, Claudia Proto, Filippo de Braud, Giancarlo Pruneri, Siranoush Manoukian

Summary: This study evaluates the performance of a tumour-to-germline diagnostic flowchart model in identifying patients with BRCA gene mutations. The results show that this model is more effective in identifying carriers of BRCA gene mutations compared to guideline-based germline testing following genetic counselling.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Meeting Abstract Oncology

Identification of SDHA germline mutations in sporadic SDHA mutant gastrointestinal stromal tumors (GIST): The need of a genetic counselling.

Margherita Nannini, Milena Urbini, Valentina Indio, Angela Schipani, Bruno Vincenzi, Marianna Silletta, Giovanni Grignani, Francesco Tolomeo, Alessandro Rizzo, Elena Fumagalli, Elena Conca, Maristella Saponara, Annalisa Astolfi, Maria A. Pantaleo

JOURNAL OF CLINICAL ONCOLOGY (2020)

Add to Collection

Article Oncology

Benefit from anti-EGFRs in RAS and BRAF wild-type metastatic transverse colon cancer: a clinical and molecular proof of concept study

Chiara Cremolini, Matteo Benelli, Elisa Fontana, Filippo Pagani, Daniele Rossini, Giovanni Fuca, Adele Busico, Elena Conca, Samantha Di Donato, Fotios Loupakis, Marta Schirripa, Sara Lonardi, Beatrice Borelli, Elena Ongaro, Katherine Eason, Federica Morano, Mariaelena Casagrande, Matteo Fassan, Anguraj Sadanandam, Filippo de Braud, Alfredo Falcone, Filippo Pietrantonio

ESMO OPEN (2019)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.